Trial intelligence / Profile preview

Ibuprofen in Sepsis Study

NCT00000574Phase 3Completed

Sponsor
Vanderbilt University
Start
Sep 1990
Modality
Small Molecules
01

Overview

A Phase 3 trial of ibuprofen in sepsis, septic shock, acute respiratory distress syndrome (ARDS), sponsored by Vanderbilt University. Started Sep 1990; status: completed.

02

Drugs

ibuprofen
03

Conditions

sepsisseptic shockacute respiratory distress syndrome (ARDS)

Beyond the preview

Go deeper on NCT00000574.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000574.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call